Related Experiment Video

Updated: May 20, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Human metapneumovirus infections on the ICU: a report of three cases

Lenneke E M Haas1, Natasja X de Rijk, Steven F T Thijsen

  • 1Department of Intensive Care Medicine, Diakonessenhuis, Utrecht, The Netherlands. lvlelyveld@diakhuis.nl.

Annals of Intensive Care
|July 21, 2012
PubMed

Insights

Human metapneumovirus (hMPV) can cause severe respiratory infections in adults, particularly the elderly and immunocompromised. This common virus should be considered in intensive care unit patients with respiratory failure.

Area of Science:

  • Virology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Human metapneumovirus (hMPV) is a known cause of respiratory illness, primarily in children.
  • While often mild, hMPV infections can lead to severe outcomes in vulnerable adult populations, including the elderly and immunocompromised.
  • The prevalence of hMPV necessitates its consideration in adult respiratory failure cases.

Purpose of the Study:

  • To highlight the potential for severe respiratory infections caused by hMPV in adults.
  • To emphasize the importance of considering hMPV in the differential diagnosis of adult respiratory failure.
  • To present clinical cases of adult hMPV infection requiring intensive care.

Main Methods:

  • Case series description of three adult patients admitted to the ICU with hMPV infection.
  • Clinical data including presentation, severity of illness, and management were reviewed.
  • Diagnostic confirmation of hMPV infection was performed.

Main Results:

  • Three adult patients, including a pregnant woman, were diagnosed with hMPV infection and admitted to the ICU.
  • Two of the three patients developed severe respiratory failure necessitating mechanical ventilation.
  • The cases illustrate the spectrum of hMPV disease in adults.

Conclusions:

  • hMPV is an important pathogen causing severe respiratory infections in adults, not just children.
  • Clinicians should consider hMPV in the differential diagnosis of adult respiratory failure, especially in at-risk individuals.
  • Early recognition and management of hMPV can be critical for patients in the ICU.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: